Importance of endomyocardial biopsy in unexplained cardiomyopathy in China: A report of 53 consecutive patients

Chinese Medical Journal

Volumn 123, Issue 7, 2010, Pages 864-870

  Tian, Zhuang ^a   Zeng, Yong ^a   Cheng, Kang An ^a   Gao, Peng ^a   Zhao, Da Chun ^a   Cui, Quan Cai ^a   Jiang, Xiu Chun ^a   Chen, Lian Feng ^a   Fang, Quan ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Biopsy; Cardiomyopathy; Dilated; Hypertrophic; Restrictive

Indexed keywords

DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY; CHINA; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC VALUE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EOSINOPHILIA; FEMALE; FLUOROSCOPY; HEART AMYLOIDOSIS; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTERNAL JUGULAR VEIN; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; RESTRICTIVE CARDIOMYOPATHY; VIRUS MYOCARDITIS;

ADOLESCENT; ADULT; AGED; BIOPSY; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; YOUNG ADULT;

EID: 77950883281     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.07.019     Document Type: Article

References (25)

1. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007; 116: 2216-2233.
2. Leatherbury L, Chandra RS, Shapiro SR, Perry LW. Value of endomyocardial biopsy in infants, children and adolescents with dilated or hypertrophic cardiomyopathy and myocarditis. J Am Coll Cardiol 1988; 12: 1547-1554.
3. Avella A, d'Amati G, Pappalardo A, Re F, Silenzi PF, Laurenzi F, et al. Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Electrophysiol 2008; 19: 1127-1134.
4. Ardehali H, Qasim A, Cappola T, Howard D, Hruban R, Hare J, et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am Heart J 2004; 147: 919-923.
5. Veinot JP. Diagnostic endomyocardial biopsy pathology: secondary myocardial diseases and other clinical indications-a review. Can J Cardiol 2002; 18: 287-296.
6. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084.
7. Jiang H, Ge J. The epidemiology and clinical management of cardiomyopathies and heart failure in China. Heart 2009; 95: 1727-1731.
8. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-842.
9. Mason JW. Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol 1978; 41: 887-892.
10. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987; 18: 619-624.
11. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982; 97: 78-92.
12. Finsterer J. Mitochondriopathies. Eur J Neurol 2004; 11: 163-186.
13. Nishino I. Autophagic vacuolar myopathies. Curr Neurol Neurosci Rep 2003; 3: 64-69.
14. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900-905.
15. Kaltenbach M, Loogen F, Olsen EG. Cardiomyopathy and myocardial biopsy. Springer: Berlin; 1978: 331-333.
16. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997; 336: 267-276.
17. Yazdani K, Maraj S, Amanullah AM. Differentiating constrictive pericarditis from restrictive cardiomyopathy. Rev Cardiovasc Med 2005; 6: 61-71.
18. Seth S, Thatai D, Sharma S, Chopera P, Talwar KK. Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India. Eur J Heart Fail 2004; 6: 723-729.
19. Fenoglio JJ, Marboe CC. Endomyocardial biopsy: an overview. Hum Pathol 1987; 18: 609-612.
20. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690-695.
21. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T, et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008; 118: 639-648.
22. Berry GJ, Jorden M. Pathology of radiation and anthracycline cardiotoxicity. Pediatr Blood Cancer 2005; 44: 630-637.
23. Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994; 23: 586-590.
24. Cunningham KS, Veinot JP, Butany J. An approach to endomyocardial biopsy interpretation. J Clin Pathol 2006; 59: 121-129.
25. Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005; 352: 362-372.